Strategy for Improving Stroke Treatment Response
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT05948566
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT05948566
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05948566. Randomized; quadruple masking; primary purpose treatment. Start 2024-03-18 (actual); primary completion 2028-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Strategy for Improving Stroke Treatment Response
- Acronym
- SISTER
- Condition
- Ischemic Stroke
- Intervention (Biological)
- TS23
- Lead sponsor
- Translational Sciences, Inc.
- Collaborator
- University of Cincinnati
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator
- Medical University of South Carolina
- Collaborator
- University of Arizona
Record details
- Record id
cardio:ct-nct05948566- Content hash
9f022f9516c49bea98cf4721ba1703bdbcfc70e9b2354956909a80d2bccbf465